MPC-2130

· Myriad Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MPC-2130, covering 2009-10-22 to 2009-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer [Phase 1]